Clinical Trial Update: Safety and Efficacy Study of Famitinib in Patients With Advanced Colorectal Adenocarcinoma（FACT） [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of famitinib in advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Famitinib (Famitinib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Colorectal Cancer Metastatic, Colorectal Cancer Recurrent | Phase 3 | Status: COMPLETED